Lory Student Center, Longs Peak, Room 302
Colorado State University
Fort Collins, CO
Driving Directions
Vic Myer, PhD
CTO, Editas Medicine
Please join us for the BUSINESS PERSPECTIVES portion of the State of Innovation Speaker Series.
Perspectives from Industry:
Harnessing the Power and Potential of
CRISPR to Transform Medicine
Where: CSU Lory Student Center, Longs Peak Room (Room 302)
When: Wednesday, February 21st, 2018
Time: 3:00-5:00 pm
A reception will follow with refreshments and light appetizers.
The event is free and open to the public, however registration is required.
About Vic Myer: Prior to joining Editas, Dr. Myer served as Executive Director and Cambridge Site Head for the Developmental and Molecular Pathways (DMP) department at the Novartis Institutes for Biomedical Research Incorporated (NIBR). Previous to Novartis, Dr. Myer was a founding scientist and group leader at Akceli, Inc., a venture-backed systems-biology company focusing on commercialization of a high-throughput cell-based micro-array technology. Dr. Myer also served as senior scientist for Millennium Pharmaceuticals and held various roles at Corning, Inc. Dr. Myer received his B.S. in biology (biochemistry) from Cornell University and his Ph.D. in molecular biophysics and biochemistry from Yale University. He was a postdoctoral research associate at the Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology.
About CSU Ventures: CSU Ventures is dedicated to the business of technology transfer and commercialization at Colorado State University. We bring innovations and technologies discovered at CSU into the marketplace for the benefit of society. Expertise in intellectual property, licensing, partnership-building, and entrepreneurship. We protect, manage and transfer CSU innovations by connecting individuals and companies with University researchers. CSU Ventures serves as a resource not only to CSU facutly and researchers, but also to industry, entreprenuers, and investors seeking to further research or commercialize a technology.